Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Microspherophakia - metaphyseal dysplasia is a very rare syndrome associating bone dysplasia with micromelic dwarfism and eye defects.
Biomarker and diagnostic research for microspherophakia-metaphyseal dysplasia syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for microspherophakia-metaphyseal dysplasia syndrome.
4 publications have been identified in PubMed for microspherophakia-metaphyseal dysplasia syndrome. Research spans Other (25%), Diagnostic / Biomarker (25%), and Case Report / Case Series (25%).
Debonnaire P (2026). [PMID: 41906617](https://pubmed.ncbi.nlm.nih.gov/41906617/). *JACC Adv*. [Diagnostic / Biomarker]
Mezher MA (2025). [PMID: 39976920](https://pubmed.ncbi.nlm.nih.gov/39976920/). *Cell Mol Biol (Noisy-le-grand)*. [Basic Science / Preclinical]
Lebrun L (2025). [PMID: 40253843](https://pubmed.ncbi.nlm.nih.gov/40253843/). *Cancer Radiother*. [Case Report / Case Series]
Misplon S (2024). [PMID: 38915071](https://pubmed.ncbi.nlm.nih.gov/38915071/). *Arch Public Health*. [Other]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:37 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center